FCF Fox Company Finance GmbH is delighted to publish the brand new “FCF Healthcare & Life Sciences Enterprise Capital Monitor – Europe 03/2024”. The Monitor is a month-to-month revealed overview of enterprise capital traits within the European Healthcare & Life Sciences sector.
As of the tip of March 2024 we establish the next present VC traits in Europe:
- Complete Healthcare & Life Sciences funding reached EUR 1,962m
- Biotech obtained 60% of the full funding quantity (EUR 1,172m) with oncology being the main indication (53%)
- In March Tubulis (Germany) secures the best transaction quantity with EUR 128m, adopted by Nouscom (Switzerland) with EUR 76m and Mission Therapeutics (United Kingdom) with EUR 51m
- M&G Investments (United Kingdom) is essentially the most lively investor (by deal quantity), adopted by Affected person Sq. Capital (United States) and Rock Springs Capital (United States)
To entry the total report, please click on right here.
By Mathias Klozenbücher and Johannes Hyperlink.